Evidence map›Paper›PMID 33920807›Full record

ArticleNutrients2021

Inadequate Content of Docosahexaenoic Acid (DHA) of Donor Human Milk for Feeding Preterm Infants: A Comparison with Mother's Own Milk at Different Stages of Lactation.

Félix Castillo, Félix-Joel Castillo-Ferrer, Begoña Cordobilla, Joan Carles Domingo

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06366893 (Enteral Supplementation With Docosahexaenoic Acid and Arachidonic Acid), which is not on this map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06366893 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Enteral Supplementation With Docosahexaenoic Acid and Arachidonic Acid (DHA-AA) in Preterm Infants. Single-center, Prospective, Randomized, Controlled, Open-label Clinical Trial

TypeinterventionalSponsorHospital Universitari Vall d'Hebron Research InstituteRan2024 to 2025Enrolled80ConditionsInfant, Premature, DiseasesArmsDHA/AA emulsion supplement for preterm infant
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. A Framework for Evaluation of New Processing Technologies in Human Milk Banking.Comprehensive reviews in food science and food safety · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. DHA supplementation and pregnancy complications.Journal of translational medicine · 2023
    Review
  8. Observational
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Félix CastilloService of Neonatology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Passeig de la Vall d'Hebron 119, E-08035 Barcelona, Spain.ORCID 0000-0003-3155-6290
Félix-Joel Castillo-FerrerService of Neonatology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Passeig de la Vall d'Hebron 119, E-08035 Barcelona, Spain.
Begoña CordobillaDepartment of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Avinguda Diagonal 643, E-08028 Barcelona, Spain.ORCID 0000-0002-0418-9387
Joan Carles DomingoDepartment of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Avinguda Diagonal 643, E-08028 Barcelona, Spain.ORCID 0000-0002-6356-0836
Universitat Autònoma de Barcelona · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A cross-sectional single-center study was designed to compare the fatty acids profile, particularly docosahexaenoic acid (DHA) levels, between milk banking samples of donor human milk and mother's own milk (MOM) for feeding preterm infants born before 32 weeks' gestation. MOM samples from 118 mothers included colostrum (1-7 days after delivery), transitional milk (9-14 days), and mature milk (15-28 days and ≥29 days). In the n-3 polyunsaturated fatty acids (PUFAs) group, the levels of α-linolenic acid (C18:3 n3) and DHA (C22:6 n3) showed opposite trends, whereas α-linolenic acid was higher in donor human milk as compared with MOM, with increasing levels as stages of lactation progressed, DHA levels were significantly lower in donor human milk than in MOM samples, which, in turn, showed decreasing levels along stages of lactation. DHA levels in donor human milk were 53% lower than in colostrum. Therefore, in preterm infants born before 32 weeks' gestation, the use of pasteurized donor human milk as exclusive feeding or combined with breastfeeding provides an inadequate supply of DHA. Nursing mothers should increase DHA intake through fish consumption or nutritional supplements with high-dose DHA while breastfeeding. Milk banking fortified with DHA would guarantee adequate DHA levels in donor human milk.

Indexed as

AdultBreast FeedingCross-Sectional StudiesDocosahexaenoic AcidsFatty AcidsFemaleGestational AgeHumansInfant, NewbornInfant, PrematureLactationMaleMilk BanksMilk, HumanMothersDocosahexaenoic AcidsFatty Acidsdocosahexaenoic aciddonor human milkpreterm infants

Identifiers

PMID33920807
PMCPMC8071120
OpenAlexW3156914306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.